🔥🐔 BizChicken 🐔🔥
Companies Similar to Avenue Therapeutics, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Athira Pharma, Inc.
ATH-1017
Athira Pharma, Inc. is a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, with its lead product, ATH-1017, in clinical trials for Alzheimer's and Parkinson's diseases.
Symbol: ATHA
Recent Price: $0.55
Industry: Biotechnology
CEO: Dr. Mark J. Litton M.B.A., Ph.D.
Sector: Healthcare
Employees: 65
Address: 18706 North Creek Parkway, Bothell, WA 98011
Phone: 425 620 8501
Last updated: 2024-12-31
Applied Therapeutics, Inc.
AT-007
Applied Therapeutics, Inc., a biopharmaceutical company, develops novel products targeting cardiovascular disease, galactosemia, and diabetic complications. Key products include AT-007 and AT-001.
About | Leadership | Leadership | Leadership | Leadership | Vision/Values | Culture | DEI | Contact | Contact | Careers | Careers | About | About | About
Symbol: APLT
Recent Price: $0.81
Industry: Biotechnology
CEO: Dr. Shoshana Shendelman Ph.D.
Sector: Healthcare
Employees: 31
Address: 545 Fifth Avenue, New York, NY 10017
Phone: 212 220 9226
Leadership
- Shoshana Shendelman, Chair, Board of Directors
- Riccardo Perfetti, Chief Medical Officer
- Les Funtleyder,
- Dale Hooks, Chief Commercial Officer
- Constantine Chinoporos, Chief Business Officer / Chief Operating Officer
- Joel Marcus,
- Jay Skyler,
- Stacy Kanter,
- Teena Lerner,
- Donald Landry M.D., Ph.D., Chair, Scientific Advisory Board
- Roy Freeman M.D.,
- Roxana Mehran M.D.,
- Lawrence Steinman M.D.,
- Gregg Stone M.D.,
- Donald d'Amico M.D.,
- Donald Landry, Chair, Scientific Advisory Board
- Roy Freeman,
- Roxana Mehran,
- Lawrence Steinman,
- Gregg Stone,
- Donald d'Amico,
Last updated: 2024-12-31
TherapeuticsMD, Inc.
IMVEXXY, BIJUVA, ANNOVERA
Therapeutics MD, Inc. operates as a women's healthcare company in the United States, providing treatments for conditions like dyspareunia and vasomotor symptoms, and offering contraceptive solutions and prenatal vitamins.
Symbol: TXMD
Recent Price: $1.03
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Marlan D. Walker J.D.
Sector: Healthcare
Employees: 1
Address: 951 Yamato Road, Boca Raton, FL 33431
Phone: 561 961 1900
Leadership
- Marlan Walker, Chief Executive Officer
- Joe Ziegler, Principle Financial Officer
Last updated: 2024-12-31
Travere Therapeutics, Inc.
Chenodal, Cholbam, Thiola, Sparsentan, TVT-058
Travere Therapeutics, Inc. is a biopharmaceutical company that focuses on identifying, developing, commercializing, and delivering therapies for the treatment of rare diseases. Its products include Chenodal, Cholbam, Thiola, and candidates like Sparsentan and TVT-058.
About | Leadership | About | About | About | Contact | Contact | Careers | Careers | About | News | About | About | About | About | About | About | News | Events | About | About | ESG | About | Jobs | Jobs | Careers | About | About | About | About
Symbol: TVTX
Recent Price: $17.32
Industry: Biotechnology
CEO: Dr. Eric M. Dube Ph.D.
Sector: Healthcare
Employees: 380
Address: 3611 Valley Centre Drive, San Diego, CA 92130
Phone: 888 969 7879
Leadership
- Eric Dube, Ph.D., President & Chief Executive Officer
- Chris Cline, CFA, Chief Financial Officer
- Angela Giannantonio, Senior Vice President, Human Resources
- Peter Heerma, Chief Commercial Officer
- Jula Inrig, M.D., Chief Medical Officer
- Casey Logan, Chief Business Officer
- Elizabeth Reed, J.D., Senior Vice President, General Counsel, Corporate Secretary
- William Rote, Ph.D., Senior Vice President, Research & Development
- Charlotte Smith, Senior Vice President, Public Affairs
- Gary A. Lyons, Chairman
- Roy D. Baynes, M.D., Ph.D.,
- Suzanne L. Bruhn, Ph.D.,
- Tim Coughlin, CPA,
- Jeffrey A. Meckler,
- John A. Orwin,
- Sandra E. Poole,
- Ron Squarer,
- Ruth Williams-Brinkley, FACHE,
Last updated: 2024-12-31
Adial Pharmaceuticals, Inc.
AD04
Adial Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics for addiction and related disorders. Its lead product, AD04, is in Phase III clinical trial for alcohol use disorder treatment.
Symbol: ADIL
Recent Price: $1.03
Industry: Biotechnology
CEO: Mr. Cary John Claiborne MBA
Sector: Healthcare
Employees: 4
Address: 1180 Seminole Trail, Charlottesville, VA 22901
Phone: 434 422 9800
Last updated: 2024-12-31
Aquestive Therapeutics, Inc.
Sympazan, Suboxone, Zuplenz, Azstarys, Libervant, Exservan
Aquestive Therapeutics, Inc. is a pharmaceutical company committed to identifying, developing, and commercializing innovative products to address unmet medical needs, both in the U.S. and globally. It specializes in oral soluble film formulations for various treatments, including neurological conditions and opioid dependence.
Symbol: AQST
Recent Price: $3.52
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Daniel Barber
Sector: Healthcare
Employees: 135
Address: 30 Technology Drive, Warren, NJ 07059
Phone: 908 941 1900
Last updated: 2024-12-31
Aerovate Therapeutics, Inc.
AV-101
Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing drugs for rare cardiopulmonary diseases, with a lead product AV-101 for pulmonary arterial hypertension.
Symbol: AVTE
Recent Price: $2.66
Industry: Biotechnology
CEO: Mr. Timothy P. Noyes M.B.A.
Sector: Healthcare
Employees: 51
Address: 930 Winter Street, Waltham, MA 02116
Phone: 617 443 2400
Last updated: 2024-12-31
Avalo Therapeutics, Inc.
AVTX-002, AVTX-007, AVTX-801
Avalo Therapeutics, Inc. is a clinical-stage precision medicine company focused on discovering, developing, and commercializing targeted therapeutics for patients with unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases.
Symbol: AVTX
Recent Price: $7.80
Industry: Biotechnology
CEO: Dr. Garry A. Neil M.D.
Sector: Healthcare
Employees: 19
Address: 540 Gaither Road, Rockville, MD 20850
Phone: 410 522 8707
Leadership
- Garry A. Neil, MD, Chairman of the Board and Chief Executive Officer
- Mittie Doyle, MD, FACR, Chief Medical Officer
- Chris Sullivan, Chief Financial Officer
- Paul Varki, Chief Legal Officer
- Lisa Hegg PhD, Senior Vice President, Program Management and Corporate Infrastructure and Clinical Operations
- Colleen Matkowski, Senior Vice President, Global Regulatory Affairs and Quality Assurance
- Dino C. Miano, PhD, Senior Vice President, CMC and Technical Operations
- June Almenoff, MD, PhD, President and Chief Medical Officer
- Mitchell Chan, Chief Financial Officer
- Jonathan Goldman, MD, CEO
- Aaron Kantoff, Managing Partner
- Gilla Kaplan, PhD, Independent Director
- Samantha Truex, CEO
Last updated: 2024-12-31
Axsome Therapeutics, Inc.
AXS-05, AXS-07, AXS-12, AXS-14
Axsome Therapeutics, Inc. is a biopharmaceutical company focused on developing novel therapies for central nervous system disorders such as major depressive disorder, migraine, narcolepsy, and fibromyalgia.
About | Leadership | Directors | About | About | About | About | About | About | Contact | Careers | Careers | About | About
Symbol: AXSM
Recent Price: $84.78
Industry: Biotechnology
CEO: Dr. Herriot Tabuteau M.D.
Sector: Healthcare
Employees: 589
Address: 22 Cortlandt Street, New York, NY 10007
Phone: 212 332 3241
Leadership
- Herriot Tabuteau, MD, CHIEF EXECUTIVE OFFICER
- Nick Pizzie, CPA, MBA, CHIEF FINANCIAL OFFICER
- Mark Jacobson, MA, CHIEF OPERATING OFFICER
- Hunter Murdock, Esq., GENERAL COUNSEL
- ari Maizel, Executive Vice President, Head of Commercial
- Mark Coleman, MD, DIRECTOR
- Roger Jeffs, PhD, DIRECTOR
- Susan Mahony, PhD, MBA, DIRECTOR
- Mark Saad, DIRECTOR
Last updated: 2024-12-31
Collegium Pharmaceutical, Inc.
Xtampza ER, Nucynta ER, Nucynta IR
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical company that develops and commercializes medicines focused on pain management, with a notable portfolio including Xtampza ER and Nucynta formulations.
Symbol: COLL
Recent Price: $28.61
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Michael Thomas Heffernan B.S. Pharm, R.Ph.
Sector: Healthcare
Employees: 197
Address: 100 Technology Center Drive, Stoughton, MA 02072
Phone: 781 713 3699
Last updated: 2024-12-31
Cumberland Pharmaceuticals Inc.
Acetadote, Caldolor, Kristalose, Omeclamox-Pak, Vaprisol, Vibativ, Redi Trex
Cumberland Pharmaceuticals Inc. focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology, offering various medications including injections and oral solutions.
Symbol: CPIX
Recent Price: $2.42
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. A. J. Kazimi MBA
Sector: Healthcare
Employees: 91
Address: 2525 West End Avenue, Nashville, TN 37203
Phone: 615 255 0068
Last updated: 2024-12-31
4D Molecular Therapeutics, Inc.
4D-125, 4D-110, 4D-310, 4D-150, 4D-710
4D Molecular Therapeutics, Inc. is a clinical-stage gene therapy company developing product candidates using adeno-associated virus vectors, focusing on ophthalmology, cardiology, and pulmonology.
About | About | Contact | News | News | News | Careers | Careers | About | DEI | Careers | Leadership | Careers | Careers
Symbol: FDMT
Recent Price: $5.30
Industry: Biotechnology
CEO: Dr. David H. Kirn M.D.
Sector: Healthcare
Employees: 201
Address: 5858 Horton Street, EmeryVille, CA 94608
Phone: 510 505 2680
Last updated: 2024-12-31
Janux Therapeutics, Inc.
Tumor Activated T Cell Engager (TRACTr), Tumor Activated Immunomodulator (TRACIr)
Janux Therapeutics is a biopharmaceutical company developing cancer therapeutics leveraging their proprietary TRACTr and TRACIr platform technologies, targeting specific antigens and improving T cell anti-tumor activity.
Symbol: JANX
Recent Price: $52.50
Industry: Biotechnology
CEO: Dr. David Alan Campbell Ph.D.
Sector: Healthcare
Employees: 64
Address: 11099 North Torrey Pines Road, La Jolla, CA 92037
Phone: 858 750 4700
Last updated: 2024-12-31
Ligand Pharmaceuticals Incorporated
Kyprolis, Evomela, Veklury, Teriparatide, Vaxneuvance, Pneumosil, Rylaze, Nexterone, Zulresso, Noxafil-IV
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company focused on developing or acquiring technologies to aid pharmaceutical companies in discovering and developing medicines. The company's commercial programs include treatments for multiple myeloma, COVID-19, osteoporosis, invasive diseases, childhood pneumonia, and acute lymphoblastic leukemia.
Symbol: LGND
Recent Price: $105.76
Industry: Biotechnology
CEO: Mr. Todd C. Davis Ph.D.
Sector: Healthcare
Employees: 58
Address: 5980 Horton Street, EmeryVille, CA 94608
Phone: 858 550 7500
Last updated: 2024-12-31
Ovid Therapeutics Inc.
OV101, OV329, OV350, OV882, OV815
Ovid Therapeutics Inc., a biopharmaceutical company based in New York, is dedicated to developing impactful medicines for neurological disorders. They have a range of drug candidates like OV101 and are involved in various clinical trials.
Our Story | Leadership | Directors | About | Our Story | Contact | About | About | About | About | About | Culture | Culture | Vision/Values | Culture | About | Culture | Culture | About | Jobs | Careers | Careers | Jobs | About | About | About | Careers | Vision/Values | About | About | About | About | About | About
Symbol: OVID
Recent Price: $0.96
Industry: Biotechnology
CEO: Dr. Jeremy Max Levin Ba Zoology, Dphil, M.D., Mb Bchir, Ph.D.
Sector: Healthcare
Employees: 40
Address: 1460 Broadway, New York, NY 10036
Phone: 646 661 7661
Leadership
- Jeremy M. Levin, D.Phil, MB BChir, Chief Executive Officer and Chairman
- Meg Alexander, President and Chief Operating Officer
- Zhong Zhong, Ph.D., Chief Scientific Officer
- Jeffrey Rona, Chief Business and Financial Officer
- Amanda Banks, M.D., Chief Development Officer
- Julia Tsai, Ph.D., Senior Vice President of Clinical Development
- Karen Bernstein, Ph.D., Director, Chair of the Compensation Committee, Member of the Audit and Nominating and Corporate Governance Committees
- Barbara G. Duncan, MBA, Director, Chair of the Audit Committee, Member of the Nominating and Corporate Governance Committee
- Bart Friedman, J.D., Lead Independent Director, Chair of the Nominating and Corporate Governance Committee, Member of the Audit and Compensation Committees
- Michael Poole, M.D., FACP, Director, Member of the Audit and Compensation Committees
- Kevin Fitzgerald, Ph.D., Director, Member of the Nominating and Corporate Governance Committee
Last updated: 2024-12-31
Phathom Pharmaceuticals, Inc.
vonoprazan
Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing treatments for gastrointestinal diseases, with significant advancements in the use of vonoprazan in clinical trials.
Symbol: PHAT
Recent Price: $8.00
Industry: Biotechnology
CEO: Ms. Terrie J. Curran
Sector: Healthcare
Employees: 452
Address: 100 Campus Drive, Florham Park, NJ 07932
Phone: 877 742 8466
Last updated: 2024-12-31
TRACON Pharmaceuticals, Inc.
therapeutics for cancer
TRACON Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing cancer therapeutics, including clinical stage products like envafolimab, YH001, TRC102, and TJ004309, with collaboration agreements with various biopharmaceutical companies.
Symbol: TCON
Recent Price: $0.03
Industry: Biotechnology
CEO: Mr. Craig R. Jalbert CIRA
Sector: Healthcare
Employees: 17
Address: 4350 La Jolla Village Drive, San Diego, CA 92122
Phone: 858 550 0780
Last updated: 2024-12-31
Trevena, Inc.
OLINVYK (Oliceridine) injection
Trevena, Inc. is a biopharmaceutical company focused on developing and commercializing novel medicines for central nervous system disorders, with products like OLINVYK and collaborations such as with Imperial College London.
Symbol: TRVN
Recent Price: $1.50
Industry: Biotechnology
CEO: Ms. Carrie L. Bourdow
Sector: Healthcare
Employees: 23
Address: 955 Chesterbrook Boulevard, Chesterbrook, PA 19087
Phone: 610 354 8840
Leadership
- Carrie L. Bourdow, President and Chief Executive Officer
- Mark A. Demitrack, MD, Senior Vice President, Chief Medical Officer
- Barry Shin, Executive Vice President, Chief Operating Officer and Chief Financial Officer
- Robert T. Yoder, Senior Vice President, Chief Business Officer, Head of Commercial Operations & Chief Compliance Officer
- Scott Braunstein, M.D., Lead Independent Director
- Dr. Mark Corrigan, Acting CEO
- Marvin H. Johnson, Jr., Board Member
- Jake R. Nunn, Board Member
- Anne M. Phillips, M.D., Board Member
- Barbara Yanni, Board Member
Last updated: 2024-12-31
Viatris Inc.
Prescription Brand Drugs, Generic Drugs, Complex Generic Drugs, Biosimilars, APIs
Viatris Inc. operates as a healthcare company worldwide, offering prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and APIs across various therapeutic areas, along with support services to help patients manage health.
Symbol: VTRS
Recent Price: $12.38
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Scott Andrew Smith
Sector: Healthcare
Employees: 33000
Address: 1000 Mylan Boulevard, Canonsburg, PA 15317
Phone: 724 514 1800
Last updated: 2024-12-31
Avenue Therapeutics, Inc.
intravenous Tramadol
Avenue Therapeutics, Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the acute/intensive care hospital setting. The company is advancing intravenous Tramadol, a synthetic dual-acting opioid, in Phase III clinical trials for post-operative acute pain treatment.
About | Leadership | Directors | About | Leadership | About | Contact | About | Contact | Contact | Careers | Leadership | Directors | About | About | Contact | About
Symbol: ATXI
Recent Price: $1.94
Industry: Biotechnology
CEO: Dr. Alexandra MacLean M.D.
Sector: Healthcare
Employees: 3
Address: 1140 Avenue of the America, New York, NY 10036
Phone: 781 652 4500
Leadership
- Jay Kranzler, MD, PhD, Chairman of the Board of Directors
- Alexandra MacLean, MD, Director
- David Jin, Interim Chief Financial Officer
- Scott A. Reines, MD, PhD, Interim Chief Medical Officer
- Michael Ryan, MS, Vice President of Clinical Operations and Program Management
- Alix MacLean, Chief Executive Officer
- Lindsay A. Rosenwald, MD, Director
- Neil Herskowitz, Director
- Curtis Oltmans, Director
- Faith Charles, Director
Last updated: 2024-12-31